Santander UK and Silicon Valley Bank are backing Berkshire-based Venture Life with a Â£ 30million revolving credit facility to fund the company’s growth strategy in consumer healthcare, following a successful capital increase in December 2020.
As part of its growth strategy, Venture Life has completed six acquisitions of consumer health companies / products. Since each of these acquisitions, the company has expanded its sales internationally as well as in the UK market, developed new line extensions, revitalized marketing strategies and transferred the manufacturing of these products in-house.
The most recent acquisition is BBI Healthcare, which it purchased earlier this month and has further diversified Venture Life’s product portfolio, which includes women’s intimate health, diabetes and athletic performance products.
Founded in 2010, Venture Life manufactures and distributes over-the-counter consumer products in the personal care market. Its product line includes oral care, proctology, women’s intimate health, diabetes / energy management, nail and foot care and more.
In 2020, almost half of its revenue came from its own brands – including Dentyl and UltraDEX – sold in UK supermarkets, Boots and through Amazon, as well as through international distributors. The remainder of its revenue comes from white label products that it develops and manufactures for other consumer healthcare companies.
Venture Life’s products are sold worldwide and it has its own presence in the UK, Italy, the Netherlands and Sweden. Venture Life’s successful growth strategy resulted in revenues that almost doubled between 2018 and 2020.
The company is headquartered in Bracknell, Berkshire and has a sales office in Breda, the Netherlands, and manufacturing and development plants in Lombardy, Italy and Gnesta, Sweden. In 2020, it quickly and effectively adapted to the pandemic, quickly starting the production of hand sanitizer as an additional source of income. He has also helped the community in northern Lombardy, Italy, by donating free disinfectant gel to local hospitals and pharmacies.
Jerry Randall, CEO of Venture Life, commented: âSantander UK and Silicon Valley Bank have invested time to really understand our business and our strategy. Their industry knowledge, tailored approach and experience supporting businesses like ours have enabled us to successfully take the next step in our growth journey.
Rob Purdew, Associate Director, Strategic Debt Solutions at Santander UK, said: âAs a high-growth European consumer healthcare company with a well-executed international strategy, Venture Life is exactly the type of company Santander UK is. equipped to support. We are delighted to act as agent and banking coordinator to provide this finance package to the company in support of its acquisition-driven growth strategy and its goal of building a broad portfolio of healthcare brands. General public.
Jon Lavin, Director of Corporate Credit Solutions at Silicon Valley Bank, said: âWe are delighted to support Venture Life Group with new funding to support the group’s growth strategy. The company has a solid track record of building successful consumer healthcare brands, both in the UK and overseas, and we look forward to working with management to build on this over the years. to come up. “
Click here for more content from our special Scaling Month, brought to you by Memory crystal.